Bausch Health Companies Inc

BHC

$29.65

+55.4% (1 year change)

Market Cap

$10.6 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$14.86 - $34.80

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-10.42x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $10.6 Billion
Enterprise Value $33.7 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +55.4%
52-Week High $34.80
52-Week Low $14.86
Beta 1.07
Outstanding Shares 358 Million
Avg 30 Day Volume 1.48 Million

Valuation

P/E Ratio -10.42
PEG -3.46
Earnings per Share -$2.86
Price to Sales Ratio 1.35
Price to Book Ratio -29.65
Revenue to Enterprise Value 4.19
EBIT to Enterprise Value 24.22
Total Debt to Enterprise Value 0.71
Debt to Equity -120.5

Profitability

Revenue $8.04 Billion
Gross Profit $5.74 Billion
EBIT $1.39 Billion
Net Income -$1.02 Billion
Profit Margin -12.66%
Quarterly Earnings Growth (YoY) +301.3%
Return on Equity 516.75%
Return on Assets -3.37%
Return on Invested Capital 5.49%

Bausch Health Companies Inc

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

News

Bausch Health Companies Q2 2021 Earnings Preview

Bausch Health Companies Q2 2021 Earnings Preview

No summary available.

Seeking Alpha Seeking Alpha, 1 day ago
Myasthenia Gravis Treatment Market Report 2021: COVID-19 Implications and Growth  Forecast to 2026  Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporation

Myasthenia Gravis Treatment Market Report 2021: COVID-19 Implications and Growth Forecast to 2026 Valeant Pharmaceuticals International, Novartis Pharmaceuticals Corporation, Apotex Corporation

No summary available.

AB Newswire AB Newswire, 5 days ago
Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

Ortho Dermatologics Announces 2021 Aspire Higher Scholarship Recipients

Scholarships Awarded to Nine Students Affected by Dermatologic Conditions LAVAL, Quebec, July 29, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ort...

PR Newswire PR Newswire, 6 days ago